Michael Yee
Stock Analyst at UBS
(2.31)
# 2,975
Out of 4,442 analysts
1345
Total ratings
44%
Success rate
0.5%
Average return
Main Sectors:
Stocks Rated by Michael Yee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PFE Pfizer | Maintained: Hold | $27 | $24.72 | +9.22% | 8 | Jun 23, 2026 | |
| APGE Apogee Therapeutics | Downgraded: Hold | $100 → $135 | $132.88 | +1.68% | 6 | Jun 23, 2026 | |
| ABBV AbbVie | Maintained: Hold | $230 | $234.76 | -2.03% | 5 | Jun 19, 2026 | |
| DNLI Denali Therapeutics | Maintained: Buy | $25 | $24.83 | +0.68% | 17 | Jun 16, 2026 | |
| JBIO Jade Biosciences | Initiated Coverage: Buy | $45 | $21.97 | +104.82% | 1 | Jun 15, 2026 | |
| IVA Inventiva | Initiated Coverage: Buy | $12 | $3.71 | +223.45% | 3 | Jun 12, 2026 | |
| IDYA IDEAYA Biosciences | Reiterated: Buy | $50 | $34.91 | +43.23% | 3 | Jun 9, 2026 | |
| RVMD Revolution Medicines | Maintained: Buy | $175 | $169.51 | +3.24% | 5 | Jun 8, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Buy | $70 | $55.53 | +26.06% | 3 | Jun 3, 2026 | |
| ORKA Oruka Therapeutics | Rated: Buy | $100 | $83.40 | +19.90% | 6 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $145 | $119.60 | +21.24% | 5 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 | $61.00 | -26.23% | 70 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $10.53 | +327.35% | 22 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 | $36.31 | +65.24% | 4 | May 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $225 | $197.19 | +14.10% | 170 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $76 | $59.43 | +27.88% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $1.76 | +240.91% | 13 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,250 | $1,107.08 | +12.91% | 6 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $390 → $400 | $347.01 | +15.27% | 185 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175 | $125.05 | +39.94% | 187 | Apr 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $80 | $37.05 | +115.92% | 14 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $18 → $13 | $15.04 | -13.56% | 18 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $545 | $468.42 | +16.35% | 124 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $20 | $5.65 | +253.98% | 5 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 → $7 | $6.04 | +15.89% | 10 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $3.87 | +81.11% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $46.39 | +29.34% | 5 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $22.94 | +96.16% | 1 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 → $50 | $17.28 | +189.35% | 2 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 → $35 | $18.50 | +89.24% | 19 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 → $60 | $51.27 | +17.03% | 15 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $2.07 | +286.47% | 4 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $30 → $28 | $33.20 | -15.66% | 5 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 → $55 | $29.18 | +88.49% | 13 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.5 → $3.5 | $4.54 | -22.91% | 8 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $6 | $9.55 | n/a | 48 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $18 | $4.44 | n/a | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $145 → $8 | $2.16 | n/a | 6 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 → $1 | $15.97 | n/a | 34 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 | $51.34 | n/a | 2 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $46 → $10 | $0.9346 | n/a | 4 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 → $15 | $6.84 | n/a | 19 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 → $30 | $3.16 | n/a | 30 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 → $7 | $26.84 | n/a | 8 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $31 | $150,000.00 | n/a | 3 | Dec 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 | $1.05 | n/a | 1 | Jul 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $5.95 | n/a | 1 | Jul 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $1 | $6.13 | n/a | 3 | Jul 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $2.90 | n/a | 2 | Oct 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2.5 | $0.0001 | n/a | 2 | Oct 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $116 | $56.50 | n/a | 59 | Sep 25, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $22.60 | n/a | 2 | Sep 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.07 | n/a | 1 | Sep 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $35.61 | n/a | 1 | Sep 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $110 | $544.33 | n/a | 43 | Feb 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $626 | $618.03 | n/a | 43 | Jan 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $57 | $8.04 | n/a | 9 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $1.54 | n/a | 1 | Dec 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $113 | $104.40 | n/a | 9 | Nov 14, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $90.53 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $45.60 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $133 | $239.08 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $80.63 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $129 | $310.00 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $115 | $218.18 | n/a | 1 | Jul 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 → $2 | $0.0001 | n/a | 5 | Jun 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 → $75 | $33.21 | n/a | 7 | Apr 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 | $17.26 | n/a | 2 | Feb 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $157 | $409.25 | n/a | 1 | Jan 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $193 | $395.10 | n/a | 1 | Jan 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 | $3.68 | n/a | 2 | Jan 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $20 | $4.45 | n/a | 8 | Nov 6, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 | $79.90 | n/a | 4 | Aug 5, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $40 | $4.63 | n/a | 4 | Jun 30, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $165.16 | n/a | 1 | Jun 29, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $0.0008 | n/a | 2 | Mar 20, 2012 |
Pfizer
Jun 23, 2026
Maintained: Hold
Price Target: $27
Current: $24.72
Upside: +9.22%
Apogee Therapeutics
Jun 23, 2026
Downgraded: Hold
Price Target: $100 → $135
Current: $132.88
Upside: +1.68%
AbbVie
Jun 19, 2026
Maintained: Hold
Price Target: $230
Current: $234.76
Upside: -2.03%
Denali Therapeutics
Jun 16, 2026
Maintained: Buy
Price Target: $25
Current: $24.83
Upside: +0.68%
Jade Biosciences
Jun 15, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $21.97
Upside: +104.82%
Inventiva
Jun 12, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $3.71
Upside: +223.45%
IDEAYA Biosciences
Jun 9, 2026
Reiterated: Buy
Price Target: $50
Current: $34.91
Upside: +43.23%
Revolution Medicines
Jun 8, 2026
Maintained: Buy
Price Target: $175
Current: $169.51
Upside: +3.24%
Bristol-Myers Squibb Company
Jun 3, 2026
Maintained: Buy
Price Target: $70
Current: $55.53
Upside: +26.06%
Oruka Therapeutics
Jun 2, 2026
Rated: Buy
Price Target: $100
Current: $83.40
Upside: +19.90%
Jun 2, 2026
Maintained: Buy
Price Target: $145
Current: $119.60
Upside: +21.24%
Jun 2, 2026
Maintained: Hold
Price Target: $45
Current: $61.00
Upside: -26.23%
Jun 2, 2026
Maintained: Buy
Price Target: $45
Current: $10.53
Upside: +327.35%
May 31, 2026
Maintained: Buy
Price Target: $60
Current: $36.31
Upside: +65.24%
May 15, 2026
Reiterated: Buy
Price Target: $225
Current: $197.19
Upside: +14.10%
May 13, 2026
Maintained: Buy
Price Target: $60 → $76
Current: $59.43
Upside: +27.88%
May 12, 2026
Maintained: Buy
Price Target: $6
Current: $1.76
Upside: +240.91%
Apr 20, 2026
Maintained: Buy
Price Target: $1,250
Current: $1,107.08
Upside: +12.91%
Apr 13, 2026
Maintained: Buy
Price Target: $390 → $400
Current: $347.01
Upside: +15.27%
Apr 8, 2026
Reiterated: Buy
Price Target: $175
Current: $125.05
Upside: +39.94%
Mar 27, 2026
Maintained: Buy
Price Target: $50 → $80
Current: $37.05
Upside: +115.92%
Mar 17, 2026
Rated: Hold
Price Target: $18 → $13
Current: $15.04
Upside: -13.56%
Mar 9, 2026
Maintained: Buy
Price Target: $545
Current: $468.42
Upside: +16.35%
Mar 5, 2026
Maintained: Buy
Price Target: $3 → $20
Current: $5.65
Upside: +253.98%
Mar 3, 2026
Maintained: Hold
Price Target: $10 → $7
Current: $6.04
Upside: +15.89%
Feb 25, 2026
Maintained: Buy
Price Target: $7
Current: $3.87
Upside: +81.11%
Feb 24, 2026
Reiterated: Buy
Price Target: $60
Current: $46.39
Upside: +29.34%
Feb 17, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $22.94
Upside: +96.16%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: $45 → $50
Current: $17.28
Upside: +189.35%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: $50 → $35
Current: $18.50
Upside: +89.24%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: $50 → $60
Current: $51.27
Upside: +17.03%
Jan 6, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $2.07
Upside: +286.47%
Jan 6, 2026
Initiated Coverage: Hold
Price Target: $30 → $28
Current: $33.20
Upside: -15.66%
Jan 6, 2026
Initiated Coverage: Buy
Price Target: $45 → $55
Current: $29.18
Upside: +88.49%
Jun 25, 2025
Maintained: Hold
Price Target: $1.5 → $3.5
Current: $4.54
Upside: -22.91%
May 27, 2025
Downgraded: Hold
Price Target: $32 → $6
Current: $9.55
Upside: n/a
Mar 13, 2025
Maintained: Buy
Price Target: $24 → $18
Current: $4.44
Upside: n/a
Mar 6, 2025
Maintained: Buy
Price Target: $145 → $8
Current: $2.16
Upside: n/a
Oct 25, 2023
Downgraded: Hold
Price Target: $3 → $1
Current: $15.97
Upside: n/a
Mar 22, 2023
Maintained: Buy
Price Target: $26
Current: $51.34
Upside: n/a
Dec 22, 2021
Downgraded: Hold
Price Target: $46 → $10
Current: $0.9346
Upside: n/a
Aug 10, 2021
Maintained: Hold
Price Target: $45 → $15
Current: $6.84
Upside: n/a
Feb 12, 2021
Downgraded: Hold
Price Target: $40 → $30
Current: $3.16
Upside: n/a
Dec 21, 2020
Maintained: Hold
Price Target: $10 → $7
Current: $26.84
Upside: n/a
Dec 21, 2018
Maintained: Buy
Price Target: $40 → $31
Current: $150,000.00
Upside: n/a
Jul 8, 2018
Reiterated: Hold
Price Target: $3.5
Current: $1.05
Upside: n/a
Jul 8, 2018
Reiterated: Buy
Price Target: $22
Current: $5.95
Upside: n/a
Jul 8, 2018
Reiterated: Hold
Price Target: $1.5 → $1
Current: $6.13
Upside: n/a
Oct 27, 2017
Reiterated: Buy
Price Target: $47
Current: $2.90
Upside: n/a
Oct 2, 2017
Reiterated: Hold
Price Target: $2.5
Current: $0.0001
Upside: n/a
Sep 25, 2017
Reiterated: Buy
Price Target: $116
Current: $56.50
Upside: n/a
Sep 4, 2017
Reiterated: Buy
Price Target: $47
Current: $22.60
Upside: n/a
Sep 4, 2017
Reiterated: Buy
Price Target: $7
Current: $3.07
Upside: n/a
Sep 4, 2017
Reiterated: Buy
Price Target: $5
Current: $35.61
Upside: n/a
Feb 23, 2017
Reiterated: Hold
Price Target: $110
Current: $544.33
Upside: n/a
Jan 3, 2017
Reiterated: Buy
Price Target: $626
Current: $618.03
Upside: n/a
Dec 30, 2016
Reiterated: Hold
Price Target: $57
Current: $8.04
Upside: n/a
Dec 20, 2016
Reiterated: Buy
Price Target: $25
Current: $1.54
Upside: n/a
Nov 14, 2016
Reiterated: Buy
Price Target: $113
Current: $104.40
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $48
Current: $90.53
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $28
Current: $45.60
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $133
Current: $239.08
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $95
Current: $80.63
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $129
Current: $310.00
Upside: n/a
Jul 28, 2016
Maintained: Buy
Price Target: $115
Current: $218.18
Upside: n/a
Jun 15, 2016
Downgraded: Hold
Price Target: $12 → $2
Current: $0.0001
Upside: n/a
Apr 20, 2016
Reiterated: Buy
Price Target: $85 → $75
Current: $33.21
Upside: n/a
Feb 5, 2016
Reiterated: Hold
Price Target: $15
Current: $17.26
Upside: n/a
Jan 25, 2016
Reiterated: Buy
Price Target: $157
Current: $409.25
Upside: n/a
Jan 25, 2016
Reiterated: Buy
Price Target: $193
Current: $395.10
Upside: n/a
Jan 4, 2016
Reiterated: Hold
Price Target: $7
Current: $3.68
Upside: n/a
Nov 6, 2015
Reiterated: Buy
Price Target: $35 → $20
Current: $4.45
Upside: n/a
Aug 5, 2015
Maintained: Hold
Price Target: $9
Current: $79.90
Upside: n/a
Jun 30, 2014
Rated: Hold
Price Target: $40
Current: $4.63
Upside: n/a
Jun 29, 2012
Upgraded: Buy
Price Target: n/a
Current: $165.16
Upside: n/a
Mar 20, 2012
Maintained: Buy
Price Target: $28
Current: $0.0008
Upside: n/a